Chandrika Christie
Washington University in St. Louis
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Chandrika Christie.
Chest | 2008
Ravi S. Aysola; Eric A. Hoffman; David S. Gierada; Sally E. Wenzel; Janice Cook-Granroth; Jaime Tarsi; Jie Zheng; Kenneth B. Schechtman; Thiruvamoor Ramkumar; Rebecca Cochran; E. Xueping; Chandrika Christie; Sean B. Fain; Talissa Altes; Mario Castro
BACKGROUND To prospectively apply an automated, quantitative three-dimensional approach to imaging and airway analysis to assess airway remodeling in asthma patients. METHODS Using quantitative software (Pulmonary Workstation, version 0.139; VIDA Diagnostics; Iowa City, IA) that enables quantitative airway segment measurements of low-dose, thin-section (0.625 to 1.25 mm), multidetector-row CT (MDCT) scans, we compared airway wall thickness (WT) and wall area (WA) in 123 subjects participating in a prospective multicenter cohort study, the National Institutes of Health Severe Asthma Research Program (patients with severe asthma, n = 63; patients with mild-to-moderate asthma, n = 35); and healthy subjects, n = 25). A subset of these subjects underwent fiberoptic bronchoscopy and endobronchial biopsies (n = 32). WT and WA measurements were corrected for total airway diameter and area: WT and WA, respectively. RESULTS Subjects with severe asthma had a significantly greater WT% than patients with mild-to-moderate asthma and healthy subjects (17.2 +/- 1.5 vs 16.5 +/- 1.6 [p = 0.014] and 16.3 +/- 1.2 [p = 0.031], respectively) and a greater WA percentage (WA%) compared to patients with mild-to-moderate asthma and healthy subjects (56.6 +/- 2.9 vs 54.7 +/- 3.3 [p = 0.005] and 54.6 +/- 2.4 [p = 0.003], respectively). Both WT% and WA% were inversely correlated with baseline FEV(1) percent predicted (r = -0.39, p < 0.0001 and r = -0.40, p < 0.0001, respectively) and positively correlated with response to a bronchodilator (r = 0.28, p = 0.002 and r = 0.35, p < 0.0001, respectively). The airway epithelial thickness measure on the biopsy sample correlated with WT% (r = 0.47; p = 0.007) and WA% (r = 0.52; p = 0.003). In the same individual, there is considerable regional heterogeneity in airway WT. CONCLUSION Patients with severe asthma have thicker airway walls as measured on MDCT scan than do patients with mild asthma or healthy subjects, which correlates with pathologic measures of remodeling and the degree of airflow obstruction. MDCT scanning may be a useful technique for assessing airway remodeling in asthma patients, but overlap among the groups limits the diagnostic value in individual subjects.
Chest | 2008
Ravi S. Aysola; Eric A. Hoffman; David S. Gierada; Sally E. Wenzel; Janice Cook-Granroth; Jaime Tarsi; Jie Zheng; Kenneth B. Schechtman; Thiruvamoor Ramkumar; Rebecca Cochran; E. Xueping; Chandrika Christie; Sean B. Fain; Talissa A. Altes; Mario Castro
BACKGROUND To prospectively apply an automated, quantitative three-dimensional approach to imaging and airway analysis to assess airway remodeling in asthma patients. METHODS Using quantitative software (Pulmonary Workstation, version 0.139; VIDA Diagnostics; Iowa City, IA) that enables quantitative airway segment measurements of low-dose, thin-section (0.625 to 1.25 mm), multidetector-row CT (MDCT) scans, we compared airway wall thickness (WT) and wall area (WA) in 123 subjects participating in a prospective multicenter cohort study, the National Institutes of Health Severe Asthma Research Program (patients with severe asthma, n = 63; patients with mild-to-moderate asthma, n = 35); and healthy subjects, n = 25). A subset of these subjects underwent fiberoptic bronchoscopy and endobronchial biopsies (n = 32). WT and WA measurements were corrected for total airway diameter and area: WT and WA, respectively. RESULTS Subjects with severe asthma had a significantly greater WT% than patients with mild-to-moderate asthma and healthy subjects (17.2 +/- 1.5 vs 16.5 +/- 1.6 [p = 0.014] and 16.3 +/- 1.2 [p = 0.031], respectively) and a greater WA percentage (WA%) compared to patients with mild-to-moderate asthma and healthy subjects (56.6 +/- 2.9 vs 54.7 +/- 3.3 [p = 0.005] and 54.6 +/- 2.4 [p = 0.003], respectively). Both WT% and WA% were inversely correlated with baseline FEV(1) percent predicted (r = -0.39, p < 0.0001 and r = -0.40, p < 0.0001, respectively) and positively correlated with response to a bronchodilator (r = 0.28, p = 0.002 and r = 0.35, p < 0.0001, respectively). The airway epithelial thickness measure on the biopsy sample correlated with WT% (r = 0.47; p = 0.007) and WA% (r = 0.52; p = 0.003). In the same individual, there is considerable regional heterogeneity in airway WT. CONCLUSION Patients with severe asthma have thicker airway walls as measured on MDCT scan than do patients with mild asthma or healthy subjects, which correlates with pathologic measures of remodeling and the degree of airflow obstruction. MDCT scanning may be a useful technique for assessing airway remodeling in asthma patients, but overlap among the groups limits the diagnostic value in individual subjects.
The Journal of Allergy and Clinical Immunology | 2012
Leonard B. Bacharier; Rebecca Cohen; Toni Schweiger; Huiquing Yin-DeClue; Chandrika Christie; Jie Zheng; Kenneth B. Schechtman; Robert C. Strunk; Mario Castro
BACKGROUND The development of asthma after respiratory syncytial virus (RSV) bronchiolitis has been demonstrated in case-control studies, although the determinants of post-RSV asthma remain undefined. OBJECTIVES We sought to evaluate the potential determinants of physician-diagnosed asthma after severe RSV bronchiolitis during infancy. METHODS We enrolled 206 children during an initial episode of severe RSV bronchiolitis at 12 months of age or less in a prospective cohort study and followed these children for up to 6 years. In a subset of 81 children, we analyzed CCL5 (RANTES) mRNA expression in upper airway epithelial cells. RESULTS Forty-eight percent of children had physician-diagnosed asthma before the seventh birthday. Independent determinants significantly associated with increased risk for physician-diagnosed asthma by the seventh birthday included maternal asthma (odds ratio [OR], 5.2; 95% CI, 1.7-15.9; P = .004), exposure to high levels of dog allergen (OR, 3.2; 95% CI, 1.3-7.7; P = .012), aeroallergen sensitivity at age 3 years (OR, 10.7; 95% CI, 2.1-55.0; P = .005), recurrent wheezing during the first 3 years of life (OR, 7.3; 95% CI, 1.2-43.3; P = .028), and CCL5 expression in nasal epithelia during acute RSV infection (OR, 3.8; 95% CI, 1.2-2.4; P < .001). White children (OR, 0.19; 95% CI, 0.04-0.93; P = .041) and children attending day care (OR, 0.18; 95% CI, 0.04-0.84; P = .029) had a decreased risk of physician-diagnosed asthma. CONCLUSIONS Approximately 50% of children who experience severe RSV bronchiolitis have a subsequent asthma diagnosis. The presence of increased CCL5 levels in nasal epithelia at the time of bronchiolitis or the development of allergic sensitization by age 3 years are associated with increased likelihood of subsequent asthma.
Journal of Allergy | 2012
Adrian Shifren; Chad A. Witt; Chandrika Christie; Mario Castro
Asthma is a chronic inflammatory airway disorder characterized by airway hyperresponsiveness and reversible airflow obstruction. Subgroups of asthma patients develop airflow obstruction that is irreversible or only partially reversible and experience an accelerated rate of lung function decline. The structural changes in the airways of these patients are referred to as airway remodeling. All elements of the airway wall are involved, and remodeled airway wall thickness is substantially increased compared to normal control airways. Airway remodeling is thought to contribute to the subphenotypes of irreversible airflow obstruction and airway hyperresponsiveness, and it has been associated with increased disease severity. Reversal of remodeling is therefore of paramount therapeutic importance, and mechanisms responsible for airway remodeling are feasible therapeutic targets for asthma treatment. This paper will focus on our current understanding of the mechanisms of airway remodeling in asthma and potential targets for future intervention.
Human Immunology | 2012
Michael Liu; Vijay Subramanian; Chandrika Christie; Mario Castro; T. Mohanakumar
american thoracic society international conference | 2011
Tiffany Turner; Huiquing Yin-DeClue; Chandrika Christie; Toni Schweiger; G Gregory; Brad Wilson; Jie Zheng; Kenneth B. Schechtman; Leonard B. Bacharier; Mario Castro
/data/revues/00916749/v122i4/S0091674908013183/ | 2011
Mario Castro; Toni Schweiger; Huiquing Yin-DeClue; Thiruvamoor Ramkumar; Chandrika Christie; Jie Zheng; Rebecca Cohen; Kenneth B. Schechtman; Robert C. Strunk; Leonard B. Bacharier
american thoracic society international conference | 2010
Tiffany Turner; Chandrika Christie; Huiquing Yin-DeClue; Toni Schweiger; Jie Zheng; Bradley S. Wilson; Kenneth B. Schechtman; Robert C. Strunk; Leonard B. Bacharier; Mario Castro
american thoracic society international conference | 2010
Luke Carlstrom; Wendy C. Moore; Eric A. Hoffman; Sean B. Fain; Sally E. Wenzel; Jie Zheng; Jaime Tarsi; Janice Cook-Granroth; David S. Gierada; Ken B. Schechtman; Chandrika Christie; Huiqing Yin-Declue; Mario Castro
american thoracic society international conference | 2010
K. D. Bhat; Chandrika Christie; Luke Carlstrom; Dana Burgdorf; Jie Zheng; Kenneth B. Schechtman; Mario Castro